Share
Share
April 26, 2023 – Ann Arbor, MI – Arbor Research Collaborative for Health and small business subsidiary, Arbor Research LLC is thrilled to announce the opening of its second office location in the vibrant Metro DC area. Strategically situated near key clients and partners including the Centers for Medicare & Medicaid Services (CMS), the Health Resources and Services Administration (HRSA), and the National Institutes of Health (NIH), the new office in McLean, Virginia is poised to further accelerate Arbor Research’s growth and impact.
“We are excited to establish a physical presence in the DC area, which will provide us with convenient meeting space to drive new business opportunities, foster collaboration, and attract top talent as we continue to expand our organization,” says Dr. Christopher Spera, President and CEO of Arbor Research. “Our headquarters will remain in Ann Arbor, Michigan, and this expansion will help us enhance our capabilities and broaden our reach.”
Located at 1640 Boro Place, McLean, Virginia, the new office boasts a modern and vibrant space designed to foster collaboration and innovation. With ample room to accommodate staff members, and the flexibility for future expansion, the office is equipped with state-of-the-art technology for seamless communication and collaboration between teams.
“As we expand our footprint, it’s imperative for us to establish a physical presence in the dynamic DC area, which serves as a strategic hub for our esteemed clients, valued funders, and trusted partners,” emphasizes Dr. Shanthy Edward, Chief Growth Officer of Arbor Research Collaborative for Health. “This new office not only bolsters our local presence, but also unlocks fresh avenues for forging impactful partnerships and pioneering research opportunities, propelling us forward in our unwavering mission to advance health research globally.”
Arbor Research Collaborative for Health is renowned for its groundbreaking research and expertise in health outcomes and health services research, with a mission to generate insights that drive better and equitable health outcomes. With the addition of the new DC area office, Arbor Research is poised for continued growth and innovation, solidifying its position as a leading global research organization.
Individuals with BSEP deficiency with one p.E297G or p.D482G mutation and one PPTM have a similarly severe disease course and low responsiveness to siEHC as those with two PPTMs.
Featuring new scientific work with internationally-known speakers, expert panels, early career investigators, and audience participation.
Dr. Stanik to assist Arbor Research with further expansion into long-term care, behavioral health, and mixed methods research
Using a mouse model of BA and human liver gene expression data collected by ChiLDReN, we were able to confirm the likely activation of this pathway known as TWEAK/FN14 in association with liver fibrosis. We further showed that inhibition of this pathway pharmacologically was associated with near complete elimination of fibrosis in the mouse model of BA.
